Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Skin Diseases”

6,207 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,207 results

Not applicableStudy completedNCT02087436
What this trial is testing

Taperloc Complete Microplasty vs Taperloc Complete Standard: Randomized Controlled Study on Bone Mineral Density

Who this might be right for
OsteoarthritisAvascular NecrosisTraumatic Arthritis+2 more
Zimmer Biomet 100
Early research (Phase 1)Study completedNCT01184092
What this trial is testing

Compare The Amount Of Tasocitinib (CP-690,550) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Three Different Tablet Versions Of Tasocitinib (CP-690,550)

Who this might be right for
Rheumatoid Arthritis
Pfizer 24
Early research (Phase 1)Study completedNCT00072592
What this trial is testing

An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

Who this might be right for
Wegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)UnknownNCT03023592
What this trial is testing

Study of Iguratimod in Sjögren's Syndrome

Who this might be right for
Sjogren's Syndrome
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292
What this trial is testing

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Who this might be right for
Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital 12
Testing effectiveness (Phase 2)Study completedNCT01031836
What this trial is testing

Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 30
Not applicableStudy completedNCT04411407
What this trial is testing

PROM Collected Via a WebApp Versus a Touch Screen Solution Among Patients With SLE

Who this might be right for
Systemic Lupus Erythematosus
Salome Kristensen 34
Post-approval studies (Phase 4)Study completedNCT01638715
What this trial is testing

A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action

Who this might be right for
Rheumatoid Arthritis
Medical University of Vienna 115
Large-scale testing (Phase 3)Study completedNCT01213017
What this trial is testing

The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Oklahoma Medical Research Foundation 20
Not applicableStudy completedNCT03495791
What this trial is testing

Educational Intervention to Improve Patient-Physician Awareness of Cardiovascular Risk in Rheumatoid Arthritis.

Who this might be right for
Rheumatoid ArthritisArthritis, Rheumatoid
Rush University Medical Center 300
Large-scale testing (Phase 3)UnknownNCT05172817
What this trial is testing

Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA Patients

Who this might be right for
PharmacokineticsSafetyEfficacy+1 more
Institute for Developing Science and Health Initiatives, Bangladesh 200
Not applicableStudy completedNCT05478018
What this trial is testing

Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus ErythematosusInterferon Deficiency
Rigshospitalet, Denmark 55
Testing effectiveness (Phase 2)Study completedNCT00426218
What this trial is testing

Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Arthritis, Juvenile Rheumatoid
Novartis 26
Testing effectiveness (Phase 2)Study completedNCT05016297
What this trial is testing

Efficacy and Safety of Baricitinib in Sjogren's Syndrome

Who this might be right for
Sjogren's Syndrome
Peking Union Medical College Hospital 87
Testing effectiveness (Phase 2)Ended earlyNCT00808210
What this trial is testing

Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 28
Not applicableUnknownNCT02832297
What this trial is testing

Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care

Who this might be right for
Arthritis, Rheumatoid
Crescendo Bioscience 318
Not applicableUnknownNCT01050010
What this trial is testing

The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary Study

Who this might be right for
Rheumatoid Arthritis
Centre Hospitalier Universitaire de Nice 30
Large-scale testing (Phase 3)Study completedNCT00036374
What this trial is testing

The Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis, Juvenile
Centocor, Inc. 123
Not applicableStudy completedNCT01078597
What this trial is testing

A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rheumatoid Arthritis (RA) Population and to Assess the Impact of Anti-MCV and the Anti-cyclic-citrullinated Peptide Antibody (Anti-CCP) Status on the Management of Irish Patients With Early RA

Who this might be right for
Rheumatoid Arthritis
AbbVie (prior sponsor, Abbott) 35
Not applicableEnded earlyNCT04606810
What this trial is testing

Measuring the Impact of an Innovative Educational Intervention in Inflammatory Arthritis

Who this might be right for
Rheumatoid Arthritis
CHU de Quebec-Universite Laval 112
Next Page